CA2323729A1 - Adp-glucose transporter of the amyloplast - Google Patents
Adp-glucose transporter of the amyloplast Download PDFInfo
- Publication number
- CA2323729A1 CA2323729A1 CA002323729A CA2323729A CA2323729A1 CA 2323729 A1 CA2323729 A1 CA 2323729A1 CA 002323729 A CA002323729 A CA 002323729A CA 2323729 A CA2323729 A CA 2323729A CA 2323729 A1 CA2323729 A1 CA 2323729A1
- Authority
- CA
- Canada
- Prior art keywords
- plant
- protein
- starch
- adp
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000002706 plastid Anatomy 0.000 title claims abstract description 27
- 239000008103 glucose Substances 0.000 title description 2
- 229920002472 Starch Polymers 0.000 claims abstract description 58
- 235000019698 starch Nutrition 0.000 claims abstract description 58
- 239000008107 starch Substances 0.000 claims abstract description 52
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 claims abstract description 51
- 210000004027 cell Anatomy 0.000 claims abstract description 48
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 20
- 230000001105 regulatory effect Effects 0.000 claims abstract description 12
- 230000004048 modification Effects 0.000 claims abstract description 5
- 238000012986 modification Methods 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 87
- 108090000623 proteins and genes Proteins 0.000 claims description 46
- 102000004169 proteins and genes Human genes 0.000 claims description 43
- 108020004414 DNA Proteins 0.000 claims description 31
- 102000053602 DNA Human genes 0.000 claims description 20
- 239000012528 membrane Substances 0.000 claims description 19
- 210000001519 tissue Anatomy 0.000 claims description 18
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 230000001965 increasing effect Effects 0.000 claims description 14
- 230000014509 gene expression Effects 0.000 claims description 9
- 229920000856 Amylose Polymers 0.000 claims description 8
- 229920000945 Amylopectin Polymers 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- WFPZSXYXPSUOPY-UHFFFAOYSA-N ADP-mannose Natural products C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O WFPZSXYXPSUOPY-UHFFFAOYSA-N 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 101710096830 DNA-3-methyladenine glycosylase Proteins 0.000 claims 2
- 102100039128 DNA-3-methyladenine glycosylase Human genes 0.000 claims 2
- 238000010348 incorporation Methods 0.000 claims 1
- 230000003381 solubilizing effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 2
- 239000013598 vector Substances 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 11
- 235000013339 cereals Nutrition 0.000 description 10
- 241000209140 Triticum Species 0.000 description 9
- 235000021307 Triticum Nutrition 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 230000032258 transport Effects 0.000 description 9
- 239000012146 running buffer Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- 102000040811 transporter activity Human genes 0.000 description 5
- 108091092194 transporter activity Proteins 0.000 description 5
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- NLEBIOOXCVAHBD-YHBSTRCHSA-N (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-dodecoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-YHBSTRCHSA-N 0.000 description 3
- 241001136782 Alca Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000172 cytosol Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 230000004952 protein activity Effects 0.000 description 2
- 108010030416 proteoliposomes Proteins 0.000 description 2
- UMCYUPVKJYJUCD-UHFFFAOYSA-M sodium 2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]acetic acid hydroxide Chemical compound [OH-].[Na+].OCC(CO)(CO)NCC(O)=O UMCYUPVKJYJUCD-UHFFFAOYSA-M 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- MRXDGVXSWIXTQL-HYHFHBMOSA-N (2s)-2-[[(1s)-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(2s)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C=O)C1NC(N)=NCC1)C(O)=O)C1=CC=CC=C1 MRXDGVXSWIXTQL-HYHFHBMOSA-N 0.000 description 1
- SUGXUUGGLDCZKB-UHFFFAOYSA-N 3,4-dichloroisocoumarin Chemical compound C1=CC=C2C(Cl)=C(Cl)OC(=O)C2=C1 SUGXUUGGLDCZKB-UHFFFAOYSA-N 0.000 description 1
- -1 6418 Chemical compound 0.000 description 1
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 1
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 1
- 108090000084 Antiporters Proteins 0.000 description 1
- 102000003669 Antiporters Human genes 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- CDGHMJJJHYKMPA-DLOVCJGASA-N Asn-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)N)N CDGHMJJJHYKMPA-DLOVCJGASA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
- VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- OLVPQBGMUGIKIW-UHFFFAOYSA-N Chymostatin Natural products C=1C=CC=CC=1CC(C=O)NC(=O)C(C(C)CC)NC(=O)C(C1NC(N)=NCC1)NC(=O)NC(C(O)=O)CC1=CC=CC=C1 OLVPQBGMUGIKIW-UHFFFAOYSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- SSHIXEILTLPAQT-WHFBIAKZSA-N Gln-Asp Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSHIXEILTLPAQT-WHFBIAKZSA-N 0.000 description 1
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 1
- 241000505545 Grapevine geminivirus Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- ZPHBZEQOLSRPAK-UHFFFAOYSA-N Phosphoramidon Natural products C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O ZPHBZEQOLSRPAK-UHFFFAOYSA-N 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- QHSSUIHLAIWXEE-IHRRRGAJSA-N Pro-Tyr-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O QHSSUIHLAIWXEE-IHRRRGAJSA-N 0.000 description 1
- 229940123573 Protein synthesis inhibitor Drugs 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108010039811 Starch synthase Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 229940123259 Transporter antagonist Drugs 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- GHXXDFDIDHIEIL-WFBYXXMGSA-N Trp-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N GHXXDFDIDHIEIL-WFBYXXMGSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 108010078114 alanyl-tryptophyl-alanine Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 108010086192 chymostatin Proteins 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- BWSDNRQVTFZQQD-AYVHNPTNSA-N phosphoramidon Chemical compound O([P@@](O)(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC=1[C]2C=CC=CC2=NC=1)C(O)=O)[C@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]1O BWSDNRQVTFZQQD-AYVHNPTNSA-N 0.000 description 1
- 108010072906 phosphoramidon Proteins 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000000007 protein synthesis inhibitor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229950009811 ubenimex Drugs 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The application relates to an ADPglucose transporter protein, or a modification or fragment thereof capable of ADPglucose transport activity which may be isolated from plant amyloplasts. The application further relates to DNA molecules encoding said transporter, plants cells transformed with the DNA molecules and also methods of regulating starch production in plants or plant cells by modulating ADPglucose transport.
Description
WO 99/47681 PC'T/GB99/00727 ADP-GLUCOSE TRANSPORTER OF THE AMYLOPLAST
The present invention relates to an ADPglucose transporter protein which regulates starch biosynthesis in plants and more particularly to the modulation of the transporter protein for the purposes of for example, producing modified starches and/or increasing starch yield. The invention also relates to methods of modulating such biosynthesis and also to genetically modified plants and plant cell lines in which starch biosynthesis is modulated.
Starch biosynthesis in plants is the major determinant of yield in agricultural production of cereals. On a world basis cereals contribute SO% of total dietaw energy supplies. and up to 7S% of the human daily calorific intake is starch. Starch also has a broad range of industrial applications (e.g. in manufacture of paper. paint and adhesives). Variation in the chemical structure of starch. determined by the ratio of amylose to amylopectin and the degree of branching in amylopectin in the starch --polymer. can significantly alter the properties of starch and the regulation of such structure is highly desirable for optimising the industrial application in which starch is beine used.
In plant storage tissues the biosynthesis of starch occurs in specialised cellular organelles called amyloplasts. The immediate soluble substrate for starch synthesis is the sugar nucleotide ADPglucose (ADPG). Amyloplasts must import the carbon required for starch synthesis and we have previously demonstrated that amyloplasts of wheat endosperm are capable of synthesising starch from either exogenous sugar (hexose) phosphates and ATP, or by direct uptake of ADPG. Recent evidence has demonstrated that in cereal endosperm the vast proportion of the enzyme which - synthesises ADPG is located in the cytoplasm (outside the amyloplast).
We have performed studies with amyloplasts which show that ADPG supports rates of starch synthesis 30-fold greater than from hexose-phosphate uptake.
Furthermore we have found during the active period of grain filling nearly all of the enzyme activity responsible for the synthesis of ADPG resides in the cytoplasm. This lead us to realise that the major source of carbon taken up by the amyloplast for starch synthesis is ADPG.
As synthesis of ADPG is located in the cytoplasm, the transport protein responsible for uptake of ADPG into amyloplasts must therefore play a pivotal role in regulating starch synthesis. T'he ADPG transporter influences not only starch yield, but also quality (a commercially important aspect of this raw material) sinee the starch synthases involved in amylose and amylopectin synthesis have different affinities for ADPG.
The present invention is founded on our identification of a protein which is integral to the membrane of amyloplasts (e.g. amyloplasts from developing wheat _,.~ endosperm) and which, we have established, is the ADPG transporter: The protein is in the inner membrane of amyloplasts and may be obtained by the procedure of Example 1 (see below).
The ADPG transporter protein may be characterised by the following features:
(a) an amino acid sequence selected from:
SMPLNAAVKM (SEQ ID NO. 1 ) GAXXXETA WACGXA
(SEQ ID NO. 2) NFRYTNFAX (SEQ ID NO. 3) _ , GATXGNXAHAMG (SEQ ID NO. 4) SVLWTEXXDXXXGFR (SEQ ID NO. ~) VXLAPXNP (SEQ ID NO. 6) PYNXAYQDXG (SEQ ID NO. 7) I
(wherein X indicates any amino acid and the other fetters represent the conventional single letter code for amino acids); and (b) a molecular weight of about 38 kDa.
A protein comprising any of the amino acid sequences listed under (a) above represents a new protein and according to a first aspect of the present invention there is provided an ADPglucose transporter protein, or a modification or frag~rlent thereof capable of ADPglucose transport activity comprising at least one amino acid sequence selected from the group of:
(i) SMPLNAAVKM;
(SEQ ID NO. 1 ) (ii) GAX~DCETAWACGXA; (SEQ ID NO. 2) _ (iii) NFRYTNFAX;
(SEQ iD NO. 3) (iv) GATXGNXAHAMG; (SEQ ID NO. 4) (v) SVLWTEXXDXXXGFR; (SEQ ID NO. 5) (vi) VXLAPXNP; and (SEQ ID NO. 6) (vii) PYNXAYQDXG. (SEQ ID NO. 7) The protein of the first aspect of the invention preferably comprises two or more of the amino acid sequences (i) - (vii) and may contain all such sequences.
When the protein contains any of the sequences (v), (vi) or (vii) they may be present in multiple copies.
It is preferred that the protein contains at least one of the amino acid sequences ' _ (i) - (iii). The protein may contain two, or all of the amino acid sequences (i) - (iii).
The protein preferably has a molecular weight in the region of 35kDa - 431:Da and more preferably a molecular weight of approximately 38 kDa.
The protein may be isolated from membranes of amv_ loplasts from cereal endosperm (c.g. spring wheat endosperm).
By ''modifying" or "controlling" the amount and / or activity of a protein in accordance with the first aspect of the invention in a starch producing plant (as compared to the amount which is present in a wild-type plant) it is possible to modulate starch production in various desirable ways. Thus according to a second aspect of the present invention there is provided a method of regulating starch production in plants or plmt cells comprising modulating the activity of the protein according to the first aspect of the invention.
According to a first embodiment of this method the activity of the ADPG
transporter may be decreased in amyloplast membranes of plant cells. A
decrease in transporter activity will favourproduction of starch with a higher proportion of amylopectin resulting in the production of "waxy" starches which can be exploited as thickening agents in food and coatings. By "waxy" we mean a starch with a lower proportion of amylose relative to amylopectin.
A decrease in activity can be achieved by exogenous addition of an agent which suppresses transporter activity (i.e. an ADPG transporter antagonist or a neutralising species raised against the transporter). Alternatively an agent may be used which _ increases the rate of breakdown of active transporter or one which decreases expression of the protein (e.g. protein synthesis inhibitors, inhibitors of post-trarlslational modification. ribozymes, antisense RNA or DNA, inhibitory transcription factors etc).
According to a second embodiment of this method the activity of the ADPG _ ' transporter is increased in amyloplast membranes of plant cells. This favours increased starch yield and will favour production of starch with a higher proportion of amylose.
Increasing amylose content increases the viscosity and gel strength of starch pastes.
v Such starches can be exploited in the production of biodegradable plastics.
High amylose content also influences gelatinization and retro'redation properties (crystallisation of cooling starch components following heating ~ of starches.
Since retrogredation of amylopcctin is a factor influencing the rate at W rich baked foods go stale, we have found that baked foods comprising starches with an increased proportion of amylose go stale less quickly and therefore have longer shelf lives. For instance, bread comprising starches containing an increased proportion of zmylose go stale less quickly than bread containing unmodifed starch.
An increase in activity can be achieved by exogenous addition of an agent that increases activity of the transporter according to the first aspect of the invention (i.e. an ADPG transporter agonist or an activating species). Alternatively an agent may be used which decreases the rate of breakdown of active transporter.
The activity may also be promoted by increasing the amount of transporter in the amyloplast membrane. This may be achieved by application of the protein to a plant or plant cell in a form in which the protein will be taken up and incorporated into the membranes of the starch producing organelles of the plant. However it is preferred that the amount of transporter in the amyloplast membrane is increased by promoting expression of the protein. This may be achieved by increasing the activity of transcription factors which promote gene expression (e.g. by administering to a plant cell the transcription factors per se or by administering phytohormones or other agents . which promote the activity of these transcription factors).
It is most preferred to increase ADPG transporter expression by genetically manipulating a plant cell.
Starch production is preferably regulated according to the first or second embodiments of the method of the invention by genetically manipulating plant material.
Such manipulation requires the use of a DNA molecule that codes for protein capable of PC?/GB99/00727 modulating ADPG transporter activity. Thus according to a third aspect of the invention there is provided a DNA molecule encoding for a protein which directly or indirectly modulates ADfG transporter protein activity, said DNA molecule being capable of being transcribed to lead to the expression of said protein.
Said protein directly or indirectly has activity for modulating ADPG
transporter protein activity such that starch production from a plant cell is regulated.
By "directly" we mean that the protein coded by the DNA molecule per se has the required activity for regulating starch production. By "indirectly'' we mean that the protein coded by the DNA molecule undergoes or mediates (e.o. as an enzyme j at least one further reaction to provide an agent effective for regulating starch production.
A preferred DNA molecule according to the third aspect of the invention codes for a ,protein of ye first aspect of the invention. Using such DNA molecules, it is possible to produce genetically modified plant material having an enhanced capability for the production of the protein of the first aspect of the invention so as to modulate ' starch production according to the second embodiment of the second aspect of the invention. These preferred DNA molecules are particularly useful for transforming a plant cell such that it will contain multiple copies of genes encoding proteins of the first aspect of the invention. Expression of the protein from such multiple copies may give rise to increased copies of proteins with transporter activity greater than is found in unmanipulated plant cells.
It will be appreciated that the base sequence of DNA molecules according to the third aspect of the invention may exhibit some base variability but still code for the same, or a functionally equivalent protein. For instance, DNA molecules which encode for the ADPG transporter or a modification or fragment of such a protein which retains ADPG transport activity, may have base changes which would not alter the amino acid sequence of the transporter expressed from the DNA molecule (e.g. due to redundancy in the genetic code). Variants of the UNA molecule may even encode a protein with altered amino acid sequence which nevertheless retains transporter's function.
It is preferred that DNA molecules according to the third aspect of the invention are propa~ ated within a suitable DNA vector to form a recombinant vector. The vector may for example be a plasmid, cosmid or virally based (e.g Gemini virus vectors). Such recombinant vectors are of utility when replicating the DNA molecule.
Furthermore recombinant vectors or derivatives thereof are highly useful for transforming plant cells or protoplasts. ' The recombinant vectors will frequently include one or more selectable markers to enable selection of cells transformed with the DNA vector and, preferably, to enable selection of cells harboring the recombinant vectors that incorporate the DNA
molecule of the third aspect of the invention. Examples of such selectable markers include genes conferring resistance to kanamycin, 6418, phosphinothricin, ampicillin or neomycin.
Recombinant vectors may also include other functional elements. For instance, the recombinant vector may be designed such that the vector and DNA molecule Integrates into the genome of a cell. In this case DNA sequences which favour targeted integration (e.g. by homologous recombination) are desirable. Alternatively recombinant vectors can be designed such that the vector will autonomously replicate in the cytosol of the cell. In this case, elements which induce DNA replication may be required in the recombinant vector. Prefer ed recombinant vectors which autonomously replicate in the cytosol of the cell will be capable of existing in a host cell in multicopies.
Multiple copies of such vectors are useful for increasing expression of protein encoded by the DNA molecule of the third aspect of the invention above levels obtainable in normal wild-type plant cells (i.e. cells which have not been genetically modified).
Wo 99/47681 PCT/GB99/0072r The recombinant vector may also further comprise a promoter or regulator to control expression of the gene as required. Furthermore the vector may also comprise a transcription terminator such as the nopaline synthase (nos) terminator).
The promoter may be an inducible promoter such as AIcR ALcA (as disclosed in WO 93!21334) or the GST system. A typical inducer for the AIcR/ALcA
promoter which may be used is cyclohexanone. lnducers such as cyclohexanone may be sprayed onto crops which have been genetically modified with DNA coding for the AIcR/ALcA
promoter operatively linked to a DNA molecule which directly or indirectly modulates ADPG transport in order that starch production may be regulated according to the methods of the invention. Commercially available safeners may be used in conjunction with inducers such as cyclohexanone (typically at doses in the range of 1 Kg/ha).
A plant may be grown in the absence of an activator of the inducible promoter and at a predetermined time (e.g. when seed endosperm is developing in cereals or tubers developing in potatoes) the foliar parts of the plant may be exposed to the activator of the promoter (e.g. by crop spraying) to regulate starch production. ' Activators may be applied to the transformed plants typically 6 - 96 hours, preferably 12 - 72 hours and most preferably 12 - 48 hours before starch production needs to be regulated.
Starch production may be closely regulated by spraying plants with the activator of the promoter at suitable times. It will be appreciated that optimal spraying times will depend upon the type of starch required (highly branched or minimal branching) and the species of plant used. By way of example only, spraying of cereal crops may be any time following the onset of flowering (approximately) day post-anthesis) up to maturity of the grain (approximately 60-70 days post-anthesis).
It will be appreciated that constitutive promoters may also be used according to the invention (e.g. the CaMV35s promoter from the cauliflower mosaic virus).
WO 99/.17681 PCT/GB99/00'27 Furthermore tissue specific promoters such as the Gliadin promoter (normally found in seeds) or the Patatin promoter (found in potato) may be used.
Other promoters which may be linked to DNA coding for proteins which directly or indirectly regulate ADPG transport are well known in the art. For instance, the promoters reviewed by Gatz (Annu Rev Plant Physiol Piant Mol Biol ~8 p89-108, 1997) may be used to transform a cell according to the second aspect of the invention.
Preferred recombinant vectors may be formed using plasmids such as pBI 101.
Bin 6. Bin I 9 or pUC or derivatives of such vectors.
The recombinant vectors may be transferred to plant cells or protoplasts by, transformation, transfection, infection, microinjection, cell fusion, protoplast fusion or ballistic bombardment. For example, transfer may be by ballistic transformation W th coated gold particles, agrobacterium mediated transformation, liposomes containing the DNA molecule, viral vectors (e.g. Gemini virus) by electroporation, by chemical transformation (e.g. treating cells with calcium chloride and Polyethylene glycol favours DNA uptake) or by means of direct DNA uptake (e.g. endocytosis).
The DNA molecule according to the third aspect of the invention may be delivered, by the abovementioned methods, to a plant cell or protoplast to be transformed without it being incorporated in a vector.
Plant material genetically modified with a DNA molecule according to the third aspect of the invention represents a fourth aspect of the invention, according to which there is provided a plant cell transformed with the DNA molecule of the third aspect of the invention. Such transformed cells are particularly useful for regulating starch production according to the method of the second aspect of the invention.
Many different types of plant material may be treated according to the method of the second aspect of the invention or trmsformed according to the fourth aspect of the invention. The material may be a growing plant, plant tissue, a plant cell line, a seed or any other suitable source of plant material which is capable of growth. If desired plant tissue may be removed from the treated plant material for further cultivation.
This tissue may be in the form of an embryo, a growing shoot tip, a bud or a root tip from a plant or growing leaf cuttings. Such tissue may be cultivated in soil or may be grown in vitro. In viu-o grown tissue may be grown under suitable conditions to give rise to a plant or alternatively the tissue may be grown to develop a plant cell line.
Plants to which the invention is applicable for modulating starch production include, but are not limited to, cereals (e.g. wheat, barley, rye, oats, maize, rice and sorghum), tubers (e.g. potatoes), root crops (e.g. sugar beet, carrots.
turnips, Swedes and cassava), legumes (e.g. peas. beans) and forage foodstuffs for animals (e.g.
grasses).
Cell lines which have been transformed according to the fourth aspect of the invention may be developed from such plants.
The plant material, plants and plant cell lines should be maintained or propagated in a suitable growth medium. When plants are grown in the ground, the environment may represent a suitable medium, although supplementation with phytohonnones, vitamins and/or carbohydrate etc may be required. Plant material, plants and plant cell lines propagated in vitro require a suitable growth medium to sustain the cells.
Such plant material (plants, plant tissue or plant cell lines) may, for example, be produced by transforming plant cells (e.g. the embryo) and growing plants from said transformed cells. The plants may be grown and seeds collected following selfing of said plants. Alternatively progeny of the transformed cells may be collected by in vitro propagation of said transformed cells. The transformed cells may be propagated using essentially standard culturing techniques which are lno~m in the art of plant science.
The invention is illustrated by the following non-limiting Example.
EJ~AMPLE 1 Protocol for Purification of the ADPG Transporter from Amyloplasts Plant Material and Amyloplast Isolation Spring wheat (Ti-iticum aestivum L. Cv. Axona) was grown under the conditions described by Tetlow et al. (1993). Endosperm tissue was obtained from developing grains taken from the mid-ear region of the head 8-14 days after anthesis (the first appearance of anthers). The dissected endosperm (25-37g fresh weight)~was used to prepare amyloplasts mechanically using the method described by Tetlow et al. ( 1994).
Isolation of Organelle Membranes Purified amyloplasts were ruptured in a buffer containing 100mM tricine-NaOH
(pH 7.8), 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride (PMSF) and IOOp.M each of leupeptin, bestatin, pepstatin, 3,4-dichloroisocoumarin;
chymostatin, I,IO-phenanthroline, phosphoramidon, and pefabloc (rupturing buffer).
All subsequent procedures were performed at 2-4°C. The ruptured amyloplasts were ' centrifuged for 10 min at IO,OOOg to remove starch and debris. The supernatant was then centrifuged for 20 min at IOO,OOOg to pellet the envelope membranes. The membrane pellet was resuspended in rupturing buffer containing 1.2M NaCI and left on ice for 30-60 min to remove extrinsic membrane proteins. The NaCI-washed membranes were pelleted (20 min, 100,000g) and the supernatant discarded, before being resuspended in rupturing buffer. The washed membranes were then finally pelleted (20 min, 100,000g) and rinsed three times in rupturing buffer before solubilization (below).
Membrane Solubilization and Protein Fractionation The washed amyloplast envelope membranes were solublized by resuspension in colunul running buffer (IOmM Tricine-NaOH (pH 7.6), 0.2% (w/v) n-dodecylmaltoside, 1 mM PMSF), followed by the addition of 40% (w/v) n-dodecylmaltoside, to give a final w0 99/47681 PC'T/GB99/0072 7 detergent concentration of 8%. After incubation on ice for 10 min the solublized membranes were diluted with running buffer to give a final n-dodecylmaltoside concentration of 1.6%. The sample was centrifuged for S min at 13,000g to remove insoluble material and the supernatant loaded onto a I cm' lliTrap (Pharmacia) Q'-"'' colurru~ which had been pre-equilibrated in runnine buffer. After loading the sample, the column was washed in 5 column volumes of running buffer before running a stepped gradient of 0-2M NaCI (in running buffer). The ?xlcm' fraction (containing ADPG
transporter activity) eluting at 90mM NaCI was retained and diluted to lOcm' in running buffer. The sample was then loaded on to a lcm' HiTrap (Pharmacia) Blue"'' at a flow rate of O.Scm' per minute (column pre-equilibrated in running buffer). After loading the sample the column was washed in S column volumes of running buffer. The purified transporter was eluted from the column with 3xlcm' of 30mM ATP in running buffer.
The purified protein was concentrated down to about O.Scm' using Amicon"''' microcentrifuge filters (lOkDa molecular weight cut off).
Reconstitution of the ADPG Transporter The solubilized ADPG transporter was reconstituted into liposomes using the procedure described by Tetlow et al. (1996) to form proteoliposomes. The transporter was orientated such that it pumped ADPG out of the liposome (i.e the reverse orientation to that found in the amyloplast where ADPG is taken into the amyloplast).
Transport of ATP, ADPG, AMP and ADP was then determined (also using the procedure described by Tetlow et al. (1996)).
Transport of various radiolabelled substrates ( 1 mM) into proteoIiposomes (containing the purified protein) was measured when the proteoliposomes were preloaded with various counter-exchange substrates ( 1 OmM). Table I shows that the transport rate was highest when ADP or AMP were used as substrates and ADPG
was used as the counter-exchange substrate. This illustrates that the isolated protein has ADPG transport activity and furthermore acts as an antiporter transporting ADPG in exchange for ADP and AMP.
WO 99/47681 PCT/GB99t00727 SUBSTRATE ( 1 COUNTER-EXCHANGE TRANSPORT RATE
mM) SUBSTRATE (IOmM) (nmol/min/mg protein) ATP Buffer 33 ADPG Buffer 32 ~P ADPG 99 References Tetlow et al. (1993) Plants 189: p597-600 Tetlow et al. ( 1994) Plants 194: p4~4-460 Tetlow et al. ( 1996) Biochem. J. 319: p7I 7-723.
SEQUENCE L.. TING
110 Tt~c -. ~ctor ~ ~ Un.ivE=: sty ci. Nanchest~-~lv TRAN~~ORTEi-: PROTEIC:
<i3C; U08E-_-~5PW0 <:191v ~:100; 7 _70 Pare~.=In Vev. ~'.0 ~:21U; 1 ~211.w lU
<212:= PRT
<213= ~Ahea~
<400> 1 Ser I!=t Pr:: Leu P.-_-n Ala Ala Val Lys Met <210> 2 <211> 14 <212> PRT
<213> Wheat ~400> 2 Gly r_a Xaa Xaa Xaa Glu Thr Ala Trp Ala Cys Gly Xaa Ala <210> 3 <211> 9 <212> PRT
<?13> Wheat <900> 3 Asn P~~e Arc Tyr T:~r Asn Phe Ala Xaa <210> 4 <211> 12 <212> PRT
<213> Wheat <400> ".
Gly A_a Thr Xaa G_y Asn Xaa Ala His Ala Met Gly <21O> 5 <211> 15 <212> PRT
<213> Wheat <400>
WO 9'9147681 16 PCT/GB99/00727 5er '~'._~ Le_ _ep T-._ Glu \~a Xaa ;ap Xaa Xaa Xaa C;i;: Jt:e ~.r<a 1 _ 10 i5 <210> 6 <211> B
<212> PRT
<213> Whea=
«100> 6 Val Xaa Le~~ ~la P: ; Xaa Fare Pro <210> 7 <211> 10 <212> PRT
<213> Wheat <900> 7 Pro Tyr Asn Xaa A'__ 'I'yr Gln Asp Xaa Gly
The present invention relates to an ADPglucose transporter protein which regulates starch biosynthesis in plants and more particularly to the modulation of the transporter protein for the purposes of for example, producing modified starches and/or increasing starch yield. The invention also relates to methods of modulating such biosynthesis and also to genetically modified plants and plant cell lines in which starch biosynthesis is modulated.
Starch biosynthesis in plants is the major determinant of yield in agricultural production of cereals. On a world basis cereals contribute SO% of total dietaw energy supplies. and up to 7S% of the human daily calorific intake is starch. Starch also has a broad range of industrial applications (e.g. in manufacture of paper. paint and adhesives). Variation in the chemical structure of starch. determined by the ratio of amylose to amylopectin and the degree of branching in amylopectin in the starch --polymer. can significantly alter the properties of starch and the regulation of such structure is highly desirable for optimising the industrial application in which starch is beine used.
In plant storage tissues the biosynthesis of starch occurs in specialised cellular organelles called amyloplasts. The immediate soluble substrate for starch synthesis is the sugar nucleotide ADPglucose (ADPG). Amyloplasts must import the carbon required for starch synthesis and we have previously demonstrated that amyloplasts of wheat endosperm are capable of synthesising starch from either exogenous sugar (hexose) phosphates and ATP, or by direct uptake of ADPG. Recent evidence has demonstrated that in cereal endosperm the vast proportion of the enzyme which - synthesises ADPG is located in the cytoplasm (outside the amyloplast).
We have performed studies with amyloplasts which show that ADPG supports rates of starch synthesis 30-fold greater than from hexose-phosphate uptake.
Furthermore we have found during the active period of grain filling nearly all of the enzyme activity responsible for the synthesis of ADPG resides in the cytoplasm. This lead us to realise that the major source of carbon taken up by the amyloplast for starch synthesis is ADPG.
As synthesis of ADPG is located in the cytoplasm, the transport protein responsible for uptake of ADPG into amyloplasts must therefore play a pivotal role in regulating starch synthesis. T'he ADPG transporter influences not only starch yield, but also quality (a commercially important aspect of this raw material) sinee the starch synthases involved in amylose and amylopectin synthesis have different affinities for ADPG.
The present invention is founded on our identification of a protein which is integral to the membrane of amyloplasts (e.g. amyloplasts from developing wheat _,.~ endosperm) and which, we have established, is the ADPG transporter: The protein is in the inner membrane of amyloplasts and may be obtained by the procedure of Example 1 (see below).
The ADPG transporter protein may be characterised by the following features:
(a) an amino acid sequence selected from:
SMPLNAAVKM (SEQ ID NO. 1 ) GAXXXETA WACGXA
(SEQ ID NO. 2) NFRYTNFAX (SEQ ID NO. 3) _ , GATXGNXAHAMG (SEQ ID NO. 4) SVLWTEXXDXXXGFR (SEQ ID NO. ~) VXLAPXNP (SEQ ID NO. 6) PYNXAYQDXG (SEQ ID NO. 7) I
(wherein X indicates any amino acid and the other fetters represent the conventional single letter code for amino acids); and (b) a molecular weight of about 38 kDa.
A protein comprising any of the amino acid sequences listed under (a) above represents a new protein and according to a first aspect of the present invention there is provided an ADPglucose transporter protein, or a modification or frag~rlent thereof capable of ADPglucose transport activity comprising at least one amino acid sequence selected from the group of:
(i) SMPLNAAVKM;
(SEQ ID NO. 1 ) (ii) GAX~DCETAWACGXA; (SEQ ID NO. 2) _ (iii) NFRYTNFAX;
(SEQ iD NO. 3) (iv) GATXGNXAHAMG; (SEQ ID NO. 4) (v) SVLWTEXXDXXXGFR; (SEQ ID NO. 5) (vi) VXLAPXNP; and (SEQ ID NO. 6) (vii) PYNXAYQDXG. (SEQ ID NO. 7) The protein of the first aspect of the invention preferably comprises two or more of the amino acid sequences (i) - (vii) and may contain all such sequences.
When the protein contains any of the sequences (v), (vi) or (vii) they may be present in multiple copies.
It is preferred that the protein contains at least one of the amino acid sequences ' _ (i) - (iii). The protein may contain two, or all of the amino acid sequences (i) - (iii).
The protein preferably has a molecular weight in the region of 35kDa - 431:Da and more preferably a molecular weight of approximately 38 kDa.
The protein may be isolated from membranes of amv_ loplasts from cereal endosperm (c.g. spring wheat endosperm).
By ''modifying" or "controlling" the amount and / or activity of a protein in accordance with the first aspect of the invention in a starch producing plant (as compared to the amount which is present in a wild-type plant) it is possible to modulate starch production in various desirable ways. Thus according to a second aspect of the present invention there is provided a method of regulating starch production in plants or plmt cells comprising modulating the activity of the protein according to the first aspect of the invention.
According to a first embodiment of this method the activity of the ADPG
transporter may be decreased in amyloplast membranes of plant cells. A
decrease in transporter activity will favourproduction of starch with a higher proportion of amylopectin resulting in the production of "waxy" starches which can be exploited as thickening agents in food and coatings. By "waxy" we mean a starch with a lower proportion of amylose relative to amylopectin.
A decrease in activity can be achieved by exogenous addition of an agent which suppresses transporter activity (i.e. an ADPG transporter antagonist or a neutralising species raised against the transporter). Alternatively an agent may be used which _ increases the rate of breakdown of active transporter or one which decreases expression of the protein (e.g. protein synthesis inhibitors, inhibitors of post-trarlslational modification. ribozymes, antisense RNA or DNA, inhibitory transcription factors etc).
According to a second embodiment of this method the activity of the ADPG _ ' transporter is increased in amyloplast membranes of plant cells. This favours increased starch yield and will favour production of starch with a higher proportion of amylose.
Increasing amylose content increases the viscosity and gel strength of starch pastes.
v Such starches can be exploited in the production of biodegradable plastics.
High amylose content also influences gelatinization and retro'redation properties (crystallisation of cooling starch components following heating ~ of starches.
Since retrogredation of amylopcctin is a factor influencing the rate at W rich baked foods go stale, we have found that baked foods comprising starches with an increased proportion of amylose go stale less quickly and therefore have longer shelf lives. For instance, bread comprising starches containing an increased proportion of zmylose go stale less quickly than bread containing unmodifed starch.
An increase in activity can be achieved by exogenous addition of an agent that increases activity of the transporter according to the first aspect of the invention (i.e. an ADPG transporter agonist or an activating species). Alternatively an agent may be used which decreases the rate of breakdown of active transporter.
The activity may also be promoted by increasing the amount of transporter in the amyloplast membrane. This may be achieved by application of the protein to a plant or plant cell in a form in which the protein will be taken up and incorporated into the membranes of the starch producing organelles of the plant. However it is preferred that the amount of transporter in the amyloplast membrane is increased by promoting expression of the protein. This may be achieved by increasing the activity of transcription factors which promote gene expression (e.g. by administering to a plant cell the transcription factors per se or by administering phytohormones or other agents . which promote the activity of these transcription factors).
It is most preferred to increase ADPG transporter expression by genetically manipulating a plant cell.
Starch production is preferably regulated according to the first or second embodiments of the method of the invention by genetically manipulating plant material.
Such manipulation requires the use of a DNA molecule that codes for protein capable of PC?/GB99/00727 modulating ADPG transporter activity. Thus according to a third aspect of the invention there is provided a DNA molecule encoding for a protein which directly or indirectly modulates ADfG transporter protein activity, said DNA molecule being capable of being transcribed to lead to the expression of said protein.
Said protein directly or indirectly has activity for modulating ADPG
transporter protein activity such that starch production from a plant cell is regulated.
By "directly" we mean that the protein coded by the DNA molecule per se has the required activity for regulating starch production. By "indirectly'' we mean that the protein coded by the DNA molecule undergoes or mediates (e.o. as an enzyme j at least one further reaction to provide an agent effective for regulating starch production.
A preferred DNA molecule according to the third aspect of the invention codes for a ,protein of ye first aspect of the invention. Using such DNA molecules, it is possible to produce genetically modified plant material having an enhanced capability for the production of the protein of the first aspect of the invention so as to modulate ' starch production according to the second embodiment of the second aspect of the invention. These preferred DNA molecules are particularly useful for transforming a plant cell such that it will contain multiple copies of genes encoding proteins of the first aspect of the invention. Expression of the protein from such multiple copies may give rise to increased copies of proteins with transporter activity greater than is found in unmanipulated plant cells.
It will be appreciated that the base sequence of DNA molecules according to the third aspect of the invention may exhibit some base variability but still code for the same, or a functionally equivalent protein. For instance, DNA molecules which encode for the ADPG transporter or a modification or fragment of such a protein which retains ADPG transport activity, may have base changes which would not alter the amino acid sequence of the transporter expressed from the DNA molecule (e.g. due to redundancy in the genetic code). Variants of the UNA molecule may even encode a protein with altered amino acid sequence which nevertheless retains transporter's function.
It is preferred that DNA molecules according to the third aspect of the invention are propa~ ated within a suitable DNA vector to form a recombinant vector. The vector may for example be a plasmid, cosmid or virally based (e.g Gemini virus vectors). Such recombinant vectors are of utility when replicating the DNA molecule.
Furthermore recombinant vectors or derivatives thereof are highly useful for transforming plant cells or protoplasts. ' The recombinant vectors will frequently include one or more selectable markers to enable selection of cells transformed with the DNA vector and, preferably, to enable selection of cells harboring the recombinant vectors that incorporate the DNA
molecule of the third aspect of the invention. Examples of such selectable markers include genes conferring resistance to kanamycin, 6418, phosphinothricin, ampicillin or neomycin.
Recombinant vectors may also include other functional elements. For instance, the recombinant vector may be designed such that the vector and DNA molecule Integrates into the genome of a cell. In this case DNA sequences which favour targeted integration (e.g. by homologous recombination) are desirable. Alternatively recombinant vectors can be designed such that the vector will autonomously replicate in the cytosol of the cell. In this case, elements which induce DNA replication may be required in the recombinant vector. Prefer ed recombinant vectors which autonomously replicate in the cytosol of the cell will be capable of existing in a host cell in multicopies.
Multiple copies of such vectors are useful for increasing expression of protein encoded by the DNA molecule of the third aspect of the invention above levels obtainable in normal wild-type plant cells (i.e. cells which have not been genetically modified).
Wo 99/47681 PCT/GB99/0072r The recombinant vector may also further comprise a promoter or regulator to control expression of the gene as required. Furthermore the vector may also comprise a transcription terminator such as the nopaline synthase (nos) terminator).
The promoter may be an inducible promoter such as AIcR ALcA (as disclosed in WO 93!21334) or the GST system. A typical inducer for the AIcR/ALcA
promoter which may be used is cyclohexanone. lnducers such as cyclohexanone may be sprayed onto crops which have been genetically modified with DNA coding for the AIcR/ALcA
promoter operatively linked to a DNA molecule which directly or indirectly modulates ADPG transport in order that starch production may be regulated according to the methods of the invention. Commercially available safeners may be used in conjunction with inducers such as cyclohexanone (typically at doses in the range of 1 Kg/ha).
A plant may be grown in the absence of an activator of the inducible promoter and at a predetermined time (e.g. when seed endosperm is developing in cereals or tubers developing in potatoes) the foliar parts of the plant may be exposed to the activator of the promoter (e.g. by crop spraying) to regulate starch production. ' Activators may be applied to the transformed plants typically 6 - 96 hours, preferably 12 - 72 hours and most preferably 12 - 48 hours before starch production needs to be regulated.
Starch production may be closely regulated by spraying plants with the activator of the promoter at suitable times. It will be appreciated that optimal spraying times will depend upon the type of starch required (highly branched or minimal branching) and the species of plant used. By way of example only, spraying of cereal crops may be any time following the onset of flowering (approximately) day post-anthesis) up to maturity of the grain (approximately 60-70 days post-anthesis).
It will be appreciated that constitutive promoters may also be used according to the invention (e.g. the CaMV35s promoter from the cauliflower mosaic virus).
WO 99/.17681 PCT/GB99/00'27 Furthermore tissue specific promoters such as the Gliadin promoter (normally found in seeds) or the Patatin promoter (found in potato) may be used.
Other promoters which may be linked to DNA coding for proteins which directly or indirectly regulate ADPG transport are well known in the art. For instance, the promoters reviewed by Gatz (Annu Rev Plant Physiol Piant Mol Biol ~8 p89-108, 1997) may be used to transform a cell according to the second aspect of the invention.
Preferred recombinant vectors may be formed using plasmids such as pBI 101.
Bin 6. Bin I 9 or pUC or derivatives of such vectors.
The recombinant vectors may be transferred to plant cells or protoplasts by, transformation, transfection, infection, microinjection, cell fusion, protoplast fusion or ballistic bombardment. For example, transfer may be by ballistic transformation W th coated gold particles, agrobacterium mediated transformation, liposomes containing the DNA molecule, viral vectors (e.g. Gemini virus) by electroporation, by chemical transformation (e.g. treating cells with calcium chloride and Polyethylene glycol favours DNA uptake) or by means of direct DNA uptake (e.g. endocytosis).
The DNA molecule according to the third aspect of the invention may be delivered, by the abovementioned methods, to a plant cell or protoplast to be transformed without it being incorporated in a vector.
Plant material genetically modified with a DNA molecule according to the third aspect of the invention represents a fourth aspect of the invention, according to which there is provided a plant cell transformed with the DNA molecule of the third aspect of the invention. Such transformed cells are particularly useful for regulating starch production according to the method of the second aspect of the invention.
Many different types of plant material may be treated according to the method of the second aspect of the invention or trmsformed according to the fourth aspect of the invention. The material may be a growing plant, plant tissue, a plant cell line, a seed or any other suitable source of plant material which is capable of growth. If desired plant tissue may be removed from the treated plant material for further cultivation.
This tissue may be in the form of an embryo, a growing shoot tip, a bud or a root tip from a plant or growing leaf cuttings. Such tissue may be cultivated in soil or may be grown in vitro. In viu-o grown tissue may be grown under suitable conditions to give rise to a plant or alternatively the tissue may be grown to develop a plant cell line.
Plants to which the invention is applicable for modulating starch production include, but are not limited to, cereals (e.g. wheat, barley, rye, oats, maize, rice and sorghum), tubers (e.g. potatoes), root crops (e.g. sugar beet, carrots.
turnips, Swedes and cassava), legumes (e.g. peas. beans) and forage foodstuffs for animals (e.g.
grasses).
Cell lines which have been transformed according to the fourth aspect of the invention may be developed from such plants.
The plant material, plants and plant cell lines should be maintained or propagated in a suitable growth medium. When plants are grown in the ground, the environment may represent a suitable medium, although supplementation with phytohonnones, vitamins and/or carbohydrate etc may be required. Plant material, plants and plant cell lines propagated in vitro require a suitable growth medium to sustain the cells.
Such plant material (plants, plant tissue or plant cell lines) may, for example, be produced by transforming plant cells (e.g. the embryo) and growing plants from said transformed cells. The plants may be grown and seeds collected following selfing of said plants. Alternatively progeny of the transformed cells may be collected by in vitro propagation of said transformed cells. The transformed cells may be propagated using essentially standard culturing techniques which are lno~m in the art of plant science.
The invention is illustrated by the following non-limiting Example.
EJ~AMPLE 1 Protocol for Purification of the ADPG Transporter from Amyloplasts Plant Material and Amyloplast Isolation Spring wheat (Ti-iticum aestivum L. Cv. Axona) was grown under the conditions described by Tetlow et al. (1993). Endosperm tissue was obtained from developing grains taken from the mid-ear region of the head 8-14 days after anthesis (the first appearance of anthers). The dissected endosperm (25-37g fresh weight)~was used to prepare amyloplasts mechanically using the method described by Tetlow et al. ( 1994).
Isolation of Organelle Membranes Purified amyloplasts were ruptured in a buffer containing 100mM tricine-NaOH
(pH 7.8), 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride (PMSF) and IOOp.M each of leupeptin, bestatin, pepstatin, 3,4-dichloroisocoumarin;
chymostatin, I,IO-phenanthroline, phosphoramidon, and pefabloc (rupturing buffer).
All subsequent procedures were performed at 2-4°C. The ruptured amyloplasts were ' centrifuged for 10 min at IO,OOOg to remove starch and debris. The supernatant was then centrifuged for 20 min at IOO,OOOg to pellet the envelope membranes. The membrane pellet was resuspended in rupturing buffer containing 1.2M NaCI and left on ice for 30-60 min to remove extrinsic membrane proteins. The NaCI-washed membranes were pelleted (20 min, 100,000g) and the supernatant discarded, before being resuspended in rupturing buffer. The washed membranes were then finally pelleted (20 min, 100,000g) and rinsed three times in rupturing buffer before solubilization (below).
Membrane Solubilization and Protein Fractionation The washed amyloplast envelope membranes were solublized by resuspension in colunul running buffer (IOmM Tricine-NaOH (pH 7.6), 0.2% (w/v) n-dodecylmaltoside, 1 mM PMSF), followed by the addition of 40% (w/v) n-dodecylmaltoside, to give a final w0 99/47681 PC'T/GB99/0072 7 detergent concentration of 8%. After incubation on ice for 10 min the solublized membranes were diluted with running buffer to give a final n-dodecylmaltoside concentration of 1.6%. The sample was centrifuged for S min at 13,000g to remove insoluble material and the supernatant loaded onto a I cm' lliTrap (Pharmacia) Q'-"'' colurru~ which had been pre-equilibrated in runnine buffer. After loading the sample, the column was washed in 5 column volumes of running buffer before running a stepped gradient of 0-2M NaCI (in running buffer). The ?xlcm' fraction (containing ADPG
transporter activity) eluting at 90mM NaCI was retained and diluted to lOcm' in running buffer. The sample was then loaded on to a lcm' HiTrap (Pharmacia) Blue"'' at a flow rate of O.Scm' per minute (column pre-equilibrated in running buffer). After loading the sample the column was washed in S column volumes of running buffer. The purified transporter was eluted from the column with 3xlcm' of 30mM ATP in running buffer.
The purified protein was concentrated down to about O.Scm' using Amicon"''' microcentrifuge filters (lOkDa molecular weight cut off).
Reconstitution of the ADPG Transporter The solubilized ADPG transporter was reconstituted into liposomes using the procedure described by Tetlow et al. (1996) to form proteoliposomes. The transporter was orientated such that it pumped ADPG out of the liposome (i.e the reverse orientation to that found in the amyloplast where ADPG is taken into the amyloplast).
Transport of ATP, ADPG, AMP and ADP was then determined (also using the procedure described by Tetlow et al. (1996)).
Transport of various radiolabelled substrates ( 1 mM) into proteoIiposomes (containing the purified protein) was measured when the proteoliposomes were preloaded with various counter-exchange substrates ( 1 OmM). Table I shows that the transport rate was highest when ADP or AMP were used as substrates and ADPG
was used as the counter-exchange substrate. This illustrates that the isolated protein has ADPG transport activity and furthermore acts as an antiporter transporting ADPG in exchange for ADP and AMP.
WO 99/47681 PCT/GB99t00727 SUBSTRATE ( 1 COUNTER-EXCHANGE TRANSPORT RATE
mM) SUBSTRATE (IOmM) (nmol/min/mg protein) ATP Buffer 33 ADPG Buffer 32 ~P ADPG 99 References Tetlow et al. (1993) Plants 189: p597-600 Tetlow et al. ( 1994) Plants 194: p4~4-460 Tetlow et al. ( 1996) Biochem. J. 319: p7I 7-723.
SEQUENCE L.. TING
110 Tt~c -. ~ctor ~ ~ Un.ivE=: sty ci. Nanchest~-~lv TRAN~~ORTEi-: PROTEIC:
<i3C; U08E-_-~5PW0 <:191v ~:100; 7 _70 Pare~.=In Vev. ~'.0 ~:21U; 1 ~211.w lU
<212:= PRT
<213= ~Ahea~
<400> 1 Ser I!=t Pr:: Leu P.-_-n Ala Ala Val Lys Met <210> 2 <211> 14 <212> PRT
<213> Wheat ~400> 2 Gly r_a Xaa Xaa Xaa Glu Thr Ala Trp Ala Cys Gly Xaa Ala <210> 3 <211> 9 <212> PRT
<?13> Wheat <900> 3 Asn P~~e Arc Tyr T:~r Asn Phe Ala Xaa <210> 4 <211> 12 <212> PRT
<213> Wheat <400> ".
Gly A_a Thr Xaa G_y Asn Xaa Ala His Ala Met Gly <21O> 5 <211> 15 <212> PRT
<213> Wheat <400>
WO 9'9147681 16 PCT/GB99/00727 5er '~'._~ Le_ _ep T-._ Glu \~a Xaa ;ap Xaa Xaa Xaa C;i;: Jt:e ~.r<a 1 _ 10 i5 <210> 6 <211> B
<212> PRT
<213> Whea=
«100> 6 Val Xaa Le~~ ~la P: ; Xaa Fare Pro <210> 7 <211> 10 <212> PRT
<213> Wheat <900> 7 Pro Tyr Asn Xaa A'__ 'I'yr Gln Asp Xaa Gly
Claims (16)
1. An ADP-Glucose transporter protein, or a modification or fiaCment thereof capable of ADPG transport activity comprising at least one amino acid sequence selected from the group of:
(i) SMPLNAAVKM (SEQ ID NO, 1) (ii) GAXXXETAWACGXA (SEQ ID NO. 2) (iii) NFRYTNFAX (SEQ ID NO. 3) wherein X indicates any amino acid and the other letters represent conventional single letter codes for amino acids.
(i) SMPLNAAVKM (SEQ ID NO, 1) (ii) GAXXXETAWACGXA (SEQ ID NO. 2) (iii) NFRYTNFAX (SEQ ID NO. 3) wherein X indicates any amino acid and the other letters represent conventional single letter codes for amino acids.
2. The ADP-Glucose transporter protein according to claim 1 wherein the protein comprises each of the amino acid sequences (i) - (iii).
3. The ADP-Glucose transporter protein according to claim 1 or 2 wherein the protein has a molecular meight of about 38kDa.
4. A DNA molecule encoding for a protein according to any one of claim 1-3, said DNA molecule being capable of being transcribed to lead to the expression of said protein.
5. A plant cell transforned with the DNA molecule according to claim 4.
6. A method of regulating starch production from a plant, plant tissue or plant cell comprising modulating activity of the amyloplast membrane ADP-Glucose transporter protein in said plant, plant tissue or plant cell.
7. The method according to claim 6 wherein the activity of the ADP-Glucose transporter is decreased.
8. The method according to claim 7 wherein stanch is produced with a higher proportion of amylopectin than found in starch from an unmodulated plant plant tissue or plant cell.
9. The method according to claim 7 wherein "waxy" starches are produced for use as thickening agents in food and coatings.
10. The method according to claim 6 wherein activity of the ADP-Glucose transporter is increased.
11. The method according to claim 10 wherein the yield of starch is increased relative to an unmodulated plant, plant tissue or plant cell.
12. The method according to claim 10 or 11 wherein starch is produced with a higher proportion of amylose than found in starch from an unmodulated plant, plant tissue or plant cell.
13. The method according to claim 12 wherein starch is produced with increased viscosity and gel strength relative to starch from an unmodulated plant, plant tissue or plant cell.
14. The method according to claim 13 wherein the starch is for incorporation in a baked food which goes stale less quickly than baked food containing starch derived from an unmodulated plant, plant tissue or plant cell.
15. The method according to any one of claims 10 - 14 wherein the plant, plant tissue or plant cell is transformed with the DNA molecule according to claims 4.
16. A 38kDa ADP-Glucose transporter protein, capable of ADPG transport activity comprising at least one amino acid sequence selected from the group of:
(i) SMPLNAAVKM (SEQ ID NO. 1) (ii) GAXXXETAWACGXA (SEQ ID NO. 2) (iii) NFRYTNFAX (SEQ ID NO. 3) wherein X indicates any amino acid and the other letters represent conventional single letter codes for amino acids; and the protein being obtainable by isolating amyloplast membranes, solubilizing said membranes and isolating protein fractions according to the protocol of Example 1.
(i) SMPLNAAVKM (SEQ ID NO. 1) (ii) GAXXXETAWACGXA (SEQ ID NO. 2) (iii) NFRYTNFAX (SEQ ID NO. 3) wherein X indicates any amino acid and the other letters represent conventional single letter codes for amino acids; and the protein being obtainable by isolating amyloplast membranes, solubilizing said membranes and isolating protein fractions according to the protocol of Example 1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9805939.7 | 1998-03-20 | ||
GBGB9805939.7A GB9805939D0 (en) | 1998-03-20 | 1998-03-20 | Starch biosynthesis |
PCT/GB1999/000727 WO1999047681A1 (en) | 1998-03-20 | 1999-03-19 | Adp-glucose transporter of the amyloplast |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2323729A1 true CA2323729A1 (en) | 1999-09-23 |
Family
ID=10828913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002323729A Abandoned CA2323729A1 (en) | 1998-03-20 | 1999-03-19 | Adp-glucose transporter of the amyloplast |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1062343A1 (en) |
JP (1) | JP2002506649A (en) |
AU (2) | AU2942199A (en) |
CA (1) | CA2323729A1 (en) |
GB (1) | GB9805939D0 (en) |
WO (2) | WO1999047682A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6866906B2 (en) | 2000-01-26 | 2005-03-15 | International Paper Company | Cut resistant paper and paper articles and method for making same |
AU2001233066B2 (en) | 2000-01-26 | 2005-04-21 | International Paper Company | Low density paperboard articles |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8826356D0 (en) * | 1988-11-10 | 1988-12-14 | Ici Plc | Adp glucose-pyrophosphorylase |
US5986174A (en) * | 1996-06-21 | 1999-11-16 | Pioneer Hi-Bred International, Inc. | Maize promoter sequence for leaf- and stalk-preferred gene expression |
-
1998
- 1998-03-20 GB GBGB9805939.7A patent/GB9805939D0/en not_active Ceased
-
1999
- 1999-03-19 WO PCT/GB1999/000728 patent/WO1999047682A1/en active Application Filing
- 1999-03-19 EP EP99910478A patent/EP1062343A1/en not_active Withdrawn
- 1999-03-19 AU AU29421/99A patent/AU2942199A/en not_active Abandoned
- 1999-03-19 AU AU29420/99A patent/AU2942099A/en not_active Abandoned
- 1999-03-19 JP JP2000536864A patent/JP2002506649A/en active Pending
- 1999-03-19 WO PCT/GB1999/000727 patent/WO1999047681A1/en not_active Application Discontinuation
- 1999-03-19 CA CA002323729A patent/CA2323729A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1062343A1 (en) | 2000-12-27 |
GB9805939D0 (en) | 1998-05-13 |
WO1999047682A1 (en) | 1999-09-23 |
AU2942099A (en) | 1999-10-11 |
JP2002506649A (en) | 2002-03-05 |
AU2942199A (en) | 1999-10-11 |
WO1999047681A1 (en) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5885802A (en) | High methionine derivatives of α-hordothionin | |
US5885801A (en) | High threonine derivatives of α-hordothionin | |
US7888554B2 (en) | Plants having improved tolerance to various types of environmental stress, their production, and polyamine metabolism-related enzyme genes | |
US20040093647A9 (en) | Method of Producing Transgenic Plants Having Improved Amino Acid Composition | |
US8455713B2 (en) | Plants with improved morphogenesis and method of constructing the same | |
RU2268301C9 (en) | Encapsulation of polypeptides in starch matrix | |
JPH05115298A (en) | Method for accumulating and increasing sterol in higher plant and composition therefor | |
EA017638B1 (en) | Modified polypeptide with dicamba monooxygenase activity, a nucleic acid molecule encoding same and methods of its use | |
EP1171619B1 (en) | Regulated expression of isopentenyl transferase in maize seeds | |
US9115338B2 (en) | Enhancement of beta-carotene content in plants | |
KR20110086203A (en) | Osmpt gene modifying plant architecture and uses theoreof | |
CA2323729A1 (en) | Adp-glucose transporter of the amyloplast | |
CN108251408A (en) | Enzyme, namely chalcone isomerase and its encoding gene, expression vector and host strain and application | |
WO2006057306A1 (en) | Poaceous plant with enhanced stress tolerance and/or productivity and method of creating the same | |
AU782201B2 (en) | Gene coding for protein involved in cytokinin signal transduction | |
NL1019308C2 (en) | Method for selecting genetically transformed cells. | |
KR101533000B1 (en) | OsMYB4P gene improving phosphate uptake efficiency in plant and uses thereof | |
WO2006125678A2 (en) | Reversible male-sterile plants | |
KR101525896B1 (en) | NMMP1 gene increasing Phytophthora blight disease resistance and uses thereof | |
AU2007202309B2 (en) | Plants having improved tolerance to various types of environmental stress, their production, and polyamine metabolism-related enzyme genes | |
AU2007237226B2 (en) | Plants with improved morphogenesis and method of constructing the same | |
JP2003125661A (en) | Plant having increased amino acid content and method for creating the same | |
MXPA01006805A (en) | Co-expression of proteins | |
JP2001333779A (en) | Method for controlling environmental resistance or proliferation of organism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |